(3aS,5S,6S,7aR)-6-(2-methylbenzimidazol-1-yl)-2-[(2-methylpyrazol-3-yl)methyl]-1,3,3a,4,5,6,7,7a-octahydroisoindol-5-ol

C21H27N5O — CID 171156043

IUPAC(3aS,5S,6S,7aR)-6-(2-methylbenzimidazol-1-yl)-2-[(2-methylpyrazol-3-yl)methyl]-1,3,3a,4,5,6,7,7a-octahydroisoindol-5-ol
SMILESCc1nc2ccccc2n1[C@H]1C[C@H]2CN(Cc3ccnn3C)C[C@H]2C[C@@H]1O
InChIInChI=1S/C21H27N5O/c1-14-23-18-5-3-4-6-19(18)26(14)20-9-15-11-25(12-16(15)10-21(20)27)13-17-7-8-22-24(17)2/h3-8,15-16,20-21,27H,9-13H2,1-2H3/t15-,16+,20-,21-/m0/s1
InChIKeyAEUZBEJLNSFZOW-GQSCTRQFSA-N
MW365.48 g/mol
LogP2.52
Rot. Bonds3

About (3aS,5S,6S,7aR)-6-(2-methylbenzimidazol-1-yl)-2-[(2-methylpyrazol-3-yl)methyl]-1,3,3a,4,5,6,7,7a-octahydroisoindol-5-ol

(3aS,5S,6S,7aR)-6-(2-methylbenzimidazol-1-yl)-2-[(2-methylpyrazol-3-yl)methyl]-1,3,3a,4,5,6,7,7a-octahydroisoindol-5-ol (PubChem CID 171156043) has the molecular formula C21H27N5O and a molecular weight of 365.48 g/mol. Its IUPAC name is (3aS,5S,6S,7aR)-6-(2-methylbenzimidazol-1-yl)-2-[(2-methylpyrazol-3-yl)methyl]-1,3,3a,4,5,6,7,7a-octahydroisoindol-5-ol.

Molecular Properties

Compound Name(3aS,5S,6S,7aR)-6-(2-methylbenzimidazol-1-yl)-2-[(2-methylpyrazol-3-yl)methyl]-1,3,3a,4,5,6,7,7a-octahydroisoindol-5-ol
PubChem CID171156043
Molecular FormulaC21H27N5O
Molecular Weight365.48 g/mol
Exact Mass365.22
IUPAC Name(3aS,5S,6S,7aR)-6-(2-methylbenzimidazol-1-yl)-2-[(2-methylpyrazol-3-yl)methyl]-1,3,3a,4,5,6,7,7a-octahydroisoindol-5-ol
SMILESCc1nc2ccccc2n1[C@H]1C[C@H]2CN(Cc3ccnn3C)C[C@H]2C[C@@H]1O
InChIInChI=1S/C21H27N5O/c1-14-23-18-5-3-4-6-19(18)26(14)20-9-15-11-25(12-16(15)10-21(20)27)13-17-7-8-22-24(17)2/h3-8,15-16,20-21,27H,9-13H2,1-2H3/t15-,16+,20-,21-/m0/s1
InChIKeyAEUZBEJLNSFZOW-GQSCTRQFSA-N
XLogP2.52
TPSA59.11 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds3
Heavy Atoms27
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500365.48
LogP ≤ 52.52
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze (3aS,5S,6S,7aR)-6-(2-methylbenzimidazol-1-yl)-2-[(2-methylpyrazol-3-yl)methyl]-1,3,3a,4,5,6,7,7a-octahydroisoindol-5-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3aS,5S,6S,7aR)-6-(2-methylbenzimidazol-1-yl)-2-[(2-methylpyrazol-3-yl)methyl]-1,3,3a,4,5,6,7,7a-octahydroisoindol-5-ol?
The IUPAC name of (3aS,5S,6S,7aR)-6-(2-methylbenzimidazol-1-yl)-2-[(2-methylpyrazol-3-yl)methyl]-1,3,3a,4,5,6,7,7a-octahydroisoindol-5-ol (CID 171156043) is (3aS,5S,6S,7aR)-6-(2-methylbenzimidazol-1-yl)-2-[(2-methylpyrazol-3-yl)methyl]-1,3,3a,4,5,6,7,7a-octahydroisoindol-5-ol.
What is the SMILES notation for (3aS,5S,6S,7aR)-6-(2-methylbenzimidazol-1-yl)-2-[(2-methylpyrazol-3-yl)methyl]-1,3,3a,4,5,6,7,7a-octahydroisoindol-5-ol?
The canonical SMILES for (3aS,5S,6S,7aR)-6-(2-methylbenzimidazol-1-yl)-2-[(2-methylpyrazol-3-yl)methyl]-1,3,3a,4,5,6,7,7a-octahydroisoindol-5-ol is Cc1nc2ccccc2n1[C@H]1C[C@H]2CN(Cc3ccnn3C)C[C@H]2C[C@@H]1O.
What is the InChIKey of (3aS,5S,6S,7aR)-6-(2-methylbenzimidazol-1-yl)-2-[(2-methylpyrazol-3-yl)methyl]-1,3,3a,4,5,6,7,7a-octahydroisoindol-5-ol?
The InChIKey is AEUZBEJLNSFZOW-GQSCTRQFSA-N. The full InChI is InChI=1S/C21H27N5O/c1-14-23-18-5-3-4-6-19(18)26(14)20-9-15-11-25(12-16(15)10-21(20)27)13-17-7-8-22-24(17)2/h3-8,15-16,20-21,27H,9-13H2,1-2H3/t15-,16+,20-,21-/m0/s1.
What are the key properties of (3aS,5S,6S,7aR)-6-(2-methylbenzimidazol-1-yl)-2-[(2-methylpyrazol-3-yl)methyl]-1,3,3a,4,5,6,7,7a-octahydroisoindol-5-ol?
(3aS,5S,6S,7aR)-6-(2-methylbenzimidazol-1-yl)-2-[(2-methylpyrazol-3-yl)methyl]-1,3,3a,4,5,6,7,7a-octahydroisoindol-5-ol has a molecular weight of 365.48 g/mol, XLogP of 2.52, 3 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (3aS,5S,6S,7aR)-6-(2-methylbenzimidazol-1-yl)-2-[(2-methylpyrazol-3-yl)methyl]-1,3,3a,4,5,6,7,7a-octahydroisoindol-5-ol is sourced from PubChem (CID 171156043), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).